ADVERTISEMENT
A photo of a dish in which cells, which look like small dots, have been enlarged and stained to make them visible to the naked eye.
New Swelling Technique Makes Cells Visible to the Naked Eye
A new technique, called Unclearing Microscopy, physically inflates and then stains cells to circumvent the need for expensive microscopes.
New Swelling Technique Makes Cells Visible to the Naked Eye
New Swelling Technique Makes Cells Visible to the Naked Eye

A new technique, called Unclearing Microscopy, physically inflates and then stains cells to circumvent the need for expensive microscopes.

A new technique, called Unclearing Microscopy, physically inflates and then stains cells to circumvent the need for expensive microscopes.

preprint

illustration of a laptop with small people filling out an assessment
Q&A: Why eLife Is Doing Away with Rejections
Jef Akst | Oct 21, 2022 | 4 min read
The journal’s executive director speaks with The Scientist about what it hopes to accomplish with its unusual new publishing model.
Illustration of blue shiny mitochondria
Worms Live Longer with Mitochondria Powered by Light: Preprint
Alejandra Manjarrez, PhD | May 24, 2022 | 4 min read
Increasing mitochondrial activity in worms by engineering a light-activated proton pump into the organelle’s membrane extends the animals’ lifespan without evidence of health decline, according to a preprint.
Woman waiting in line at the airport, carrying a bag and standing next to two other suitcases. She is wearing a N95 face mask.
SARS-CoV-2 in the Air: What’s Known and What Isn’t
Alejandra Manjarrez, PhD | Feb 18, 2022 | 9 min read
Evidence suggests that COVID-19 is primarily an airborne disease. Yet the details of how transmission occurs are still debated and frequently misunderstood.
Artist’s rendering of brain fog: a bright blue drawing of a brain sits inside of a pink drawing of a head in profile surrounded by miscellaneous shapes
Brain Fog Caused by Long COVID and Chemo Appear Similar
Dan Robitzski | Jan 28, 2022 | 6 min read
Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.
illustration of a laptop surrounded by data visualization plots
Opinion: In Defense of Preprints
Richard Sever and John Inglis | Nov 11, 2021 | 3 min read
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
Double exposure of woman hands working on computer and DNA hologram drawing
Brave New Publishing World
Bob Grant | Nov 1, 2021 | 4 min read
Preprints are likely here to stay. The press, the public, and the research community must adapt to this relatively recent model of scientific publishing if we are to extract its benefits while avoiding its pitfalls.
Illustration depicting peers reviewing a paper
Opinion: The Problem with Preprints
Michael Mullins | Nov 1, 2021 | 4 min read
Preprints can be valuable additions to the scientific literature. But we must start seeing them as perishable commodities rather than akin to peer-reviewed, published studies.
A conceptual illustration of computers, hands on mice, a virus
A Surge in Pandemic Research Shines a Spotlight on Preprints
Diana Kwon | Sep 10, 2021 | 5 min read
Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.
Illustration of a person confused looking at a computer
When Researchers Sound the Alarm on Problematic Papers
Shawna Williams | Sep 1, 2021 | 10+ min read
Finding and reporting an irregularity in a published study can lead people down an unexpected path.
Blue stethoscope resting on a pile of folders filled with papers
Ivermectin (Still) Lacks Scientific Support as a COVID-19 Drug
Catherine Offord | Aug 2, 2021 | 3 min read
A Cochrane review bolsters scientists’ advice that ivermectin should not be used against the disease outside of clinical trials, while a study claiming to have found beneficial effects in patients was withdrawn following allegations of data manipulation.
preprint academic publishing science research covid-19 coronavirus pandemic reproducibility
Opinion: The Rise of Preprints Is No Cause for Alarm
Jonny Coates | Apr 14, 2021 | 4 min read
At a time of fast-paced science and rampant misinformation, can we trust the non–peer-reviewed literature?
asapbio preprints in the public eye media journalism science covid-19 sars-cov-2 pandemic coronavirus reporting newspaper tv
Opinion: Preprints in the Public Eye
Jigisha Patel | Mar 18, 2021 | 4 min read
ASAPbio has developed resources for preprint servers, institutions, scientists, and journalists to promote the responsible reporting of research in the media.
Doctors Consider Convalescent T Cell Therapy for COVID-19
Abby Olena, PhD | Nov 6, 2020 | 3 min read
Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
covid-19, SARS-CoV-2, pandemic, preprint, research, journal, peer review
New Journal to Publish Reviews of COVID-19 Preprints
Amanda Heidt | Jun 29, 2020 | 2 min read
The open access publication will use AI to identify the most pressing manuscripts in need of peer review.
Special Report
women gender gap science stem academic scholarly publishing research producivity pandemic coronavirus covid-19 shutdown childcare daycare school parenting arxiv biorxiv medrxiv stem
Gender Gap in Research Output Widens During Pandemic
Katarina Zimmer | Jun 25, 2020 | 8 min read
Experts identify childcare, which tends to fall to women, as one likely cause for the relative decrease in women’s scientific productivity compared with men’s.
sars-cov-2 research pandemic coronavirus covid-19 preprints retraction research integrity academic publishing sars hiv vaccine rt-pcr
Opinion: Don’t Disparage the Pace of COVID-19 Research
John D. Loike and Salomon Amar | Jun 22, 2020 | 4 min read
Fast science—with all its warts—is making unprecedented progress in the fight against COVID-19.
covid COVID-19 pandemic antibody IgG IgM coronavirus immunity SARS-CoV-2
Studies Report Rapid Loss of COVID-19 Antibodies
Amanda Heidt | Jun 19, 2020 | 3 min read
The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.
special report
How (Not) to Do an Antibody Survey for SARS-CoV-2
Catherine Offord | Apr 28, 2020 | 10+ min read
Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.
coronavirus covid-19 sars-cov-2 peer review academic publishing scientific journals new england journal of medicine journal of virology
Journals, Peer Reviewers Cope with Surge in COVID-19 Publications
Claire Jarvis | Mar 17, 2020 | 3 min read
Coronavirus experts are swamped with reading submissions, which they’re working through as quickly as possible.
ADVERTISEMENT